• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人多能干细胞分化为心肌细胞及心肌细胞的富集。

Differentiation and enrichment of cardiomyocytes from human pluripotent stem cells.

机构信息

Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA.

出版信息

J Mol Cell Cardiol. 2012 Jun;52(6):1203-12. doi: 10.1016/j.yjmcc.2012.03.012. Epub 2012 Mar 30.

DOI:10.1016/j.yjmcc.2012.03.012
PMID:22484618
Abstract

Human cardiomyocytes derived from pluripotent stem cells hold great promise for cardiac cell therapy, disease modeling, drug discovery, and the study of developmental biology. Reaching these potentials fully requires the development of methods that enable efficient and robust generation of cardiomyocytes with expected characteristics. This review summarizes and discusses up-to-date methods that have been used to derive and enrich human cardiomyocytes from pluripotent stem cells, provides a brief overview of in vitro and in vivo characterization of these cardiomyocytes, and considers future advancement needed to further harness the power of these cells.

摘要

人多能干细胞诱导分化而来的心肌细胞在心脏细胞治疗、疾病建模、药物研发和发育生物学研究等领域具有广阔的应用前景。为了充分发挥这些潜能,需要开发出能够高效且稳定地获得具有预期特性的心肌细胞的方法。本文总结并讨论了目前用于从多能干细胞中获得和富集人心肌细胞的方法,简要概述了这些心肌细胞的体外和体内鉴定,并探讨了进一步利用这些细胞的功能所需的未来进展。

相似文献

1
Differentiation and enrichment of cardiomyocytes from human pluripotent stem cells.人多能干细胞分化为心肌细胞及心肌细胞的富集。
J Mol Cell Cardiol. 2012 Jun;52(6):1203-12. doi: 10.1016/j.yjmcc.2012.03.012. Epub 2012 Mar 30.
2
Cardiomyocytes from human pluripotent stem cells in regenerative medicine and drug discovery.再生医学与药物研发中来自人类多能干细胞的心肌细胞。
Trends Pharmacol Sci. 2009 Oct;30(10):536-45. doi: 10.1016/j.tips.2009.07.001. Epub 2009 Sep 15.
3
Cardiomyocytes derived from human embryonic stem cells - characteristics and utility for drug discovery.源自人类胚胎干细胞的心肌细胞——特性及在药物发现中的应用
Curr Opin Drug Discov Devel. 2009 Jan;12(1):133-40.
4
Prospects for pluripotent stem cell-derived cardiomyocytes in cardiac cell therapy and as disease models.多能干细胞衍生心肌细胞在心脏细胞治疗及作为疾病模型方面的前景。
J Cell Biochem. 2009 Jul 1;107(4):592-9. doi: 10.1002/jcb.22164.
5
Cardiomyocytes derived from pluripotent stem cells: progress and prospects from China.多能干细胞衍生的心肌细胞:来自中国的进展和前景。
Exp Cell Res. 2013 Jan 15;319(2):120-5. doi: 10.1016/j.yexcr.2012.09.011. Epub 2012 Sep 25.
6
Perspective from the heart: the potential of human pluripotent stem cell-derived cardiomyocytes.从心脏角度看:人类多能干细胞衍生的心肌细胞的潜力。
J Cell Biochem. 2013 Jan;114(1):39-46. doi: 10.1002/jcb.24359.
7
Pluripotent stem cell models of cardiac disease and their implication for drug discovery and development.心脏疾病的多能干细胞模型及其对药物发现和开发的意义。
Trends Mol Med. 2011 Sep;17(9):475-84. doi: 10.1016/j.molmed.2011.05.001. Epub 2011 Jun 22.
8
Regulation of 'stemness' and stem cell differentiation by microRNAs.微小RNA对“干性”和干细胞分化的调控
IDrugs. 2009 Aug;12(8):492-6.
9
Impacts of recent advances in cardiovascular regenerative medicine on clinical therapies and drug discovery.心血管再生医学的最新进展对临床治疗和药物发现的影响。
Pharmacol Ther. 2010 May;126(2):109-18. doi: 10.1016/j.pharmthera.2010.01.010. Epub 2010 Feb 13.
10
Cardiomyocyte differentiation of human induced pluripotent stem cells.人诱导多能干细胞的心肌细胞分化
Circulation. 2009 Oct 13;120(15):1513-23. doi: 10.1161/CIRCULATIONAHA.109.868885. Epub 2009 Sep 28.

引用本文的文献

1
Spaceflight alters protein levels and gene expression associated with stress response and metabolic characteristics in human cardiac spheroids.太空飞行会改变与人类心脏球体应激反应和代谢特征相关的蛋白质水平和基因表达。
Biomaterials. 2025 Jun;317:123080. doi: 10.1016/j.biomaterials.2024.123080. Epub 2025 Jan 6.
2
A comprehensive analysis of gene expression changes in a high replicate and open-source dataset of differentiating hiPSC-derived cardiomyocytes.高重复和开源的人诱导多能干细胞来源的心肌细胞分化数据集的基因表达变化的综合分析。
Sci Rep. 2021 Aug 4;11(1):15845. doi: 10.1038/s41598-021-94732-1.
3
The Emergence of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs) as a Platform to Model Arrhythmogenic Diseases.
人诱导多能干细胞衍生心肌细胞(hiPSC-CMs)作为心律失常疾病模型的平台的出现。
Int J Mol Sci. 2020 Jan 19;21(2):657. doi: 10.3390/ijms21020657.
4
Cardiac Toxicity From Ethanol Exposure in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.人诱导多能干细胞衍生心肌细胞中乙醇暴露引起的心脏毒性。
Toxicol Sci. 2019 May 1;169(1):280-292. doi: 10.1093/toxsci/kfz038.
5
Implementing genome-driven personalized cardiology in clinical practice.在临床实践中实施基于基因组的个性化心脏病学。
J Mol Cell Cardiol. 2018 Feb;115:142-157. doi: 10.1016/j.yjmcc.2018.01.008. Epub 2018 Jan 16.
6
Culture in Glucose-Depleted Medium Supplemented with Fatty Acid and 3,3',5-Triiodo-l-Thyronine Facilitates Purification and Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes.在补充有脂肪酸和3,3',5-三碘-L-甲状腺原氨酸的葡萄糖缺乏培养基中培养有助于人多能干细胞衍生心肌细胞的纯化和成熟。
Front Endocrinol (Lausanne). 2017 Oct 9;8:253. doi: 10.3389/fendo.2017.00253. eCollection 2017.
7
Optimizing stem cells for cardiac repair: Current status and new frontiers in regenerative cardiology.优化用于心脏修复的干细胞:再生心脏病学的现状与新前沿
World J Stem Cells. 2017 Jan 26;9(1):9-25. doi: 10.4252/wjsc.v9.i1.9.
8
Human iPSC-derived cardiomyocytes and tissue engineering strategies for disease modeling and drug screening.用于疾病建模和药物筛选的人诱导多能干细胞衍生心肌细胞及组织工程策略。
Biotechnol Adv. 2017 Jan-Feb;35(1):77-94. doi: 10.1016/j.biotechadv.2016.12.002. Epub 2016 Dec 20.
9
G-protein Coupled Receptor Signaling in Pluripotent Stem Cell-derived Cardiovascular Cells: Implications for Disease Modeling.多能干细胞衍生心血管细胞中的 G 蛋白偶联受体信号传导:对疾病建模的影响。
Front Cell Dev Biol. 2015 Dec 9;3:76. doi: 10.3389/fcell.2015.00076. eCollection 2015.
10
Efficient differentiation of cardiomyocytes from human pluripotent stem cells with growth factors.利用生长因子从人多能干细胞高效分化心肌细胞。
Methods Mol Biol. 2015;1299:115-31. doi: 10.1007/978-1-4939-2572-8_9.